Compounds > platinum
Page last updated: 2024-08-22

platinum and Angiogenesis, Pathologic

platinum has been researched along with Angiogenesis, Pathologic in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (27.27)29.6817
2010's7 (63.64)24.3611
2020's1 (9.09)2.80

Authors

AuthorsStudies
Fan, K; Ge, M; Huang, X; Jiang, B; Jiang, W; Xue, B; Yan, X; Yang, Z1
Ashihara, K; Fujiwara, S; Kanemura, M; Kawaguchi, H; Ohmichi, M; Sasaki, H; Takai, M; Tanabe, A; Tanaka, T; Tanaka, Y; Terai, Y; Tsunetoh, S1
Hiura, K; Iwaki-Egawa, S; Komori, H; Shiraishi, A; Suzuki, C; Takamura, K; Watanabe, Y; Yamamoto, M1
Castelo, PS; Garcia-Ruiz, JP; Matesanz Garcia, AI; Souza, AP1
Bamias, A; Chatziioannou, A; Dimopoulos, MA; Gavalas, NG; Haidopoulos, D; Kostouros, E; Koutsoukos, K; Liontos, M; Lykka, M; Papadodima, O; Pilalis, E; Rodolakis, A; Terpos, E; Thomakos, N; Trachana, SP; Tzannis, K; Vlachos, G1
Albrecht, M; Brabec, V; Donnelly, K; Kasparkova, J; Mueller, T; Muenzner, JK; Novohradsky, V; Rehm, T; Schmitt, F; Schobert, R1
Ab, O; Bartle, LM; Coccia, J; Lanieri, L; Lee, J; Pinkas, J; Ponte, JF; Ruiz-Soto, R; Themeles, M; Zhou, Y1
Daignault, S; Dy, GK; Gadgeel, SM; Kalemkerian, GP; Ramnath, N; Schneider, BJ; Wozniak, AJ1
Delauter, BJ; Egorin, MJ; Eiseman, JL; Gervais, AC; Grim, A; Hamburger, DR; Joseph, E; Pluim, D; Potter, DM; Schellens, JH; Zamboni, WC; Zuhowski, EG1
Barnés, CM; Barnes, KR; Haskel, A; Lippard, SJ; Mukhopadhyay, S; Short, SM1
Bhattacharya, R; Mukherjee, P1

Reviews

1 review(s) available for platinum and Angiogenesis, Pathologic

ArticleYear
Biological properties of "naked" metal nanoparticles.
    Advanced drug delivery reviews, 2008, Aug-17, Volume: 60, Issue:11

    Topics: Animals; Drug Delivery Systems; Gold; Humans; Metal Nanoparticles; Neoplasms; Neovascularization, Pathologic; Platinum; Silver

2008

Trials

1 trial(s) available for platinum and Angiogenesis, Pathologic

ArticleYear
Phase II trial of sunitinib maintenance therapy after platinum-based chemotherapy in patients with extensive-stage small cell lung cancer.
    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2011, Volume: 6, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Early Termination of Clinical Trials; Etoposide; Female; Humans; Indoles; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neovascularization, Pathologic; Patient Dropouts; Platinum; Pyrroles; Small Cell Lung Carcinoma; Sunitinib; Treatment Outcome

2011

Other Studies

9 other study(ies) available for platinum and Angiogenesis, Pathologic

ArticleYear
Mitochondria-targeted nanozymes eliminate oxidative damage in retinal neovascularization disease.
    Journal of controlled release : official journal of the Controlled Release Society, 2022, Volume: 350

    Topics: Animals; Catalase; Hydrogen Peroxide; Hypoxia; Liposomes; Mice; Mitochondria; Neovascularization, Pathologic; Oxidative Stress; Oxygen; Platinum; Reactive Oxygen Species; Retinal Neovascularization; Superoxide Dismutase

2022
Gemcitabine as a molecular targeting agent that blocks the Akt cascade in platinum-resistant ovarian cancer.
    Journal of ovarian research, 2014, Apr-09, Volume: 7

    Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Cisplatin; Deoxycytidine; Disease Models, Animal; Drug Resistance, Neoplasm; Female; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Matrix Metalloproteinase 9; Mice; Neoplasm Metastasis; Neovascularization, Pathologic; Ovarian Neoplasms; Platinum; Proto-Oncogene Proteins c-akt; Signal Transduction; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays

2014
MMP-9/ANC score as a predictive biomarker for efficacy of bevacizumab plus platinum doublet chemotherapy in patients with advanced or recurrent non-squamous non-small cell lung cancer.
    Cancer biomarkers : section A of Disease markers, 2015, Volume: 15, Issue:4

    Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Biomarkers, Tumor; Blood Cell Count; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Female; Humans; Male; Matrix Metalloproteinase 9; Middle Aged; Neoplasm Recurrence, Local; Neovascularization, Pathologic; Neutrophils; Paclitaxel; Platinum; Vascular Endothelial Growth Factor A

2015
Thiosemicarbazone-Pt(II) Complex Causes a Growth Inhibitory Effect on Human Mesenchymal Stem Cells.
    Medicinal chemistry (Shariqah (United Arab Emirates)), 2015, Volume: 11, Issue:7

    Topics: Cell Proliferation; Cytoskeleton; Humans; Immunomodulation; Mesenchymal Stem Cells; Models, Molecular; Molecular Conformation; Neoplasm Metastasis; Neovascularization, Pathologic; Organometallic Compounds; Platinum; Thiosemicarbazones

2015
The Development of an Angiogenic Protein "Signature" in Ovarian Cancer Ascites as a Tool for Biologic and Prognostic Profiling.
    PloS one, 2016, Volume: 11, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Ascites; Ascitic Fluid; Carboplatin; Female; Humans; Middle Aged; Neovascularization, Pathologic; Ovarian Neoplasms; Platinum; Prognosis; Vascular Endothelial Growth Factor A

2016
Effects of histidin-2-ylidene vs. imidazol-2-ylidene ligands on the anticancer and antivascular activity of complexes of ruthenium, iridium, platinum, and gold.
    Journal of inorganic biochemistry, 2016, Volume: 163

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Chick Embryo; Gold; Humans; Imidazoles; Iridium; Melanoma; Mice; Neovascularization, Pathologic; Platinum; Ruthenium; Xenograft Model Antitumor Assays

2016
Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha-Targeting Antibody-Drug Conjugate, Potentiates the Activity of Standard of Care Therapeutics in Ovarian Cancer Models.
    Neoplasia (New York, N.Y.), 2016, Volume: 18, Issue:12

    Topics: Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Carboplatin; Cell Cycle; Cell Line, Tumor; Disease Models, Animal; Drug Resistance, Neoplasm; Drug Synergism; Female; Folate Receptor 1; Humans; Immunoconjugates; Maytansine; Mice; Neovascularization, Pathologic; Ovarian Neoplasms; Platinum; Xenograft Model Antitumor Assays

2016
Inter- and intratumoral disposition of platinum in solid tumors after administration of cisplatin.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2002, Volume: 8, Issue:9

    Topics: Animals; Antineoplastic Agents; Area Under Curve; Carcinoma, Non-Small-Cell Lung; Cisplatin; DNA Adducts; DNA, Neoplasm; Factor VIII; Female; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, SCID; Microdialysis; Models, Biological; Neoplasm Proteins; Neovascularization, Pathologic; Platinum; Specific Pathogen-Free Organisms; Tissue Distribution; Xenograft Model Antitumor Assays

2002
Conjugated platinum(IV)-peptide complexes for targeting angiogenic tumor vasculature.
    Bioconjugate chemistry, 2008, Volume: 19, Issue:1

    Topics: Amino Acid Motifs; Animals; Cattle; CD13 Antigens; Cell Line, Tumor; Cell Proliferation; Cisplatin; Dose-Response Relationship, Drug; Endothelial Cells; Humans; Inhibitory Concentration 50; Integrin alphaV; Neoplasms; Neovascularization, Pathologic; Oligopeptides; Organometallic Compounds; Peptides; Platinum

2008